| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432417A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 06/30/2004 | EP1037880B1 Retinoic acid mimetic anilides |
| 06/30/2004 | EP0977600B1 Contrast agents targetting receptors associated with angiogenesis |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1155579C Synthesis of histamine dihydrochloride |
| 06/30/2004 | CN1155578C Production of cyclic acid |
| 06/30/2004 | CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/29/2004 | US6756395 Cyclization of n-(4-cyanomethylphenyl)methanesulfonamides with ethylenediamine to form n-(4-imidazol-2-ylmethyl)-phenyl) -methanesulfonamides; incontinence, sexual dysfunction, nasal congestion, and cns disorders; alpha 1 adrenergic agonists |
| 06/29/2004 | US6756385 Imidazole derivatives |
| 06/29/2004 | US6756216 Batch processing using nucleophilic compound |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/29/2004 | CA2207404C Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 06/29/2004 | CA2178604C Novel imidazole derivative and process for producing the same |
| 06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment |
| 06/24/2004 | WO2004024060A3 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122234 Growth Hormone secretagogues |
| 06/24/2004 | US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 06/24/2004 | US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent |
| 06/24/2004 | US20040122073 E.g., 1-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-2,5-dioxo-4-phenyl-3-(phenylmethyl)-4-imidazolidineacetamide; enzme enzyme inhibitors of the blood Factor VIIa complex; myocardial infarction; antiischemic agents; brain disorders , |
| 06/24/2004 | US20040122053 2-(substituted-phenyl)amino-imidazoline derivatives |
| 06/24/2004 | US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 06/24/2004 | US20040122026 N-[2-Methyl-3-(piperidinomethyl)phenyl]-3-[3-(3,5-dichlorobenzyl)-2-dicyanomethylidene imidazolidin-1-yl]propionamide for example; autoimmune or allergic diseases |
| 06/24/2004 | US20040122024 Effective against mutations; such as 2,3-Dihydro-4-ethyl-1-(3-methylphenylamino)-5-phenyl-1H-imidazole-2-thione |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | DE10258671A1 New bis(trifluoromethyl)amide salts of cationic heterocyles, useful e.g. as ionic liquids and as intermediates for pharmaceuticals and plant-protection agents |
| 06/24/2004 | CA2505887A1 Pyrazole and imidazole compounds and uses thereof |
| 06/23/2004 | EP1431292A1 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors |
| 06/23/2004 | EP1431291A1 1-Aryl-4-cyano-3-cyclopropylpyrazole derivatives as ectoparasiticidal agents |
| 06/23/2004 | EP1431290A1 Novel nitrogenous compound and use thereof |
| 06/23/2004 | EP1430032A2 Substituted amides for the treatment of neurological disorders |
| 06/23/2004 | EP1430028A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 06/23/2004 | CN1506350A Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/17/2004 | WO2004050657A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 06/17/2004 | WO2004050643A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/17/2004 | WO2004050636A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 06/17/2004 | WO2004050635A2 Imidazol derivatives having affinity for alpha 2 receptors activity |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004050610A2 Modulators of melanocortin receptor |
| 06/17/2004 | WO2004050039A2 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/17/2004 | WO2004037796A3 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 06/17/2004 | WO2004037769A3 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant |
| 06/17/2004 | WO2004030611A3 Non-nucleoside reverse transcriptase inhibitors |
| 06/17/2004 | WO2004013282A3 Bis (amino acid) molecular scaffolds |
| 06/17/2004 | US20040116711 Pesticides, drugs, fungicides; reacting p-toluenesulfony isocyanate with phosphorus oxychloride or phosgene in presence of phase transfer agent and base |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116496 Asymmetric Disulfides and methods of using same |
| 06/17/2004 | US20040116495 Compounds and methods |
| 06/17/2004 | US20040116489 (1S*,2S*,4S*,5R*,6S*) 2-Amino-4-(3-phenylthioureido)-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid for treatment of neurological disorders and psychiatric disorders |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116476 Imidazolidinone compounds |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116417 Thiohydantoins and use thereof for treating diabetes |
| 06/17/2004 | US20040116414 Succinoyl aminopyrazoles and related compounds |
| 06/17/2004 | US20040116404 Sulphones which modulate the action of gamma secretase |
| 06/17/2004 | US20040116357 For prophylaxis and therapy of hyperglycemia such as diabetes, diabetic complications or obesity |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | CA2508914A1 Modulators of melanocortin receptor |
| 06/17/2004 | CA2508581A1 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/17/2004 | CA2507624A1 Imidazole-derivatives as factor xa inhibitors |
| 06/17/2004 | CA2506741A1 Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1153766C Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/15/2004 | US6750355 Derivatives of 2-aminophenol; providing good oxidative coloration of hair and for providing acceptable light fastness, selectivity, fastness to shampooing |
| 06/15/2004 | US6750352 Polymerizable molten salt monomer, electrolyte composition and electrochemical cell |
| 06/15/2004 | US6750339 Primary intermediates for oxidative coloration of hair |
| 06/15/2004 | US6750337 Couplers for use in oxidative hair dyeing |
| 06/15/2004 | US6750322 Guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 06/15/2004 | US6750254 Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/15/2004 | CA2192714C Quasiturbine (qurbine) zero vibration - continuous combustion rotary engine, compressor and pump |
| 06/10/2004 | WO2004048922A2 Bead-based detection of ligand-gpcr-g protein complexes |
| 06/10/2004 | WO2004048341A1 Novel heteroaryl derivative |
| 06/10/2004 | WO2004048319A1 Novel benzamide compounds for use in mch receptor related disorders |
| 06/10/2004 | WO2004048309A1 Vitamin d receptor modulators |
| 06/10/2004 | WO2004047744A2 3-heterocyclic benzylamide derivatives as potassium channel openers |
| 06/10/2004 | US20040110964 use for regulating the degree of polymerization during the polymerization of monomers, such as homo- or copolymerization of chloroprene and/or dichlorobutadiene |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110811 3-carbonyl- and sulfonyl derivatives: e.g., 1-Benzyl-3-naphthylcarbonyl-5,5-diphenylimidazolidine -2,4-dione; chymase and/or tryptase inhibition activity; especially treating chorioretinopathy, glaucoma, myopia or asthenopia. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110806 Dipeptide derivatives |